Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37026 - 37050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	EFNA5	1946	downregulated	entinostat results in decreased expression of EFNA5 mRNA	5q21.3	A21037
Entinostat	Investigational	EFNB2	1948	downregulated	entinostat results in decreased expression of EFNB2 mRNA	13q33.3	A21037
Entinostat	Investigational	EFR3A	23167	upregulated	entinostat results in increased expression of EFR3A mRNA	8q24.22	A21035
Entinostat	Investigational	EGF	1950	downregulated	entinostat results in decreased expression of EGF mRNA	4q25	A21037
Entinostat	Investigational	EGF	1950	upregulated	entinostat results in increased expression of EGF mRNA	4q25	A21035
Entinostat	Investigational	EGFL7	51162	upregulated	entinostat results in increased expression of EGFL7 mRNA	9q34.3	A21035
Entinostat	Investigational	EGFLAM	133584	upregulated	entinostat results in increased expression of EGFLAM mRNA	5p13.2-p13.1	A21035
Entinostat	Investigational	EGLN1	54583	downregulated	entinostat results in decreased expression of EGLN1 mRNA	1q42.2	A21035
Entinostat	Investigational	EGR1	1958	downregulated	entinostat results in decreased expression of EGR1 mRNA	5q31.2	A21037
Entinostat	Investigational	EGR3	1960	downregulated	entinostat results in decreased expression of EGR3 mRNA	8p21.3	A21037
Entinostat	Investigational	EGR4	1961	downregulated	entinostat results in decreased expression of EGR4 mRNA	2p13.2	A21037
Entinostat	Investigational	EHBP1L1	254102	upregulated	entinostat results in increased expression of EHBP1L1 mRNA	11q13.1	A21035
Entinostat	Investigational	EHD2	30846	upregulated	entinostat results in increased expression of EHD2 mRNA	19q13.33	A21037 A21035
Entinostat	Investigational	EHD4	30844	upregulated	entinostat results in increased expression of EHD4 mRNA	15q15.1	A21035
Entinostat	Investigational	EIF2AK4	440275	upregulated	entinostat results in increased expression of EIF2AK4 mRNA	15q15.1	A21037
Entinostat	Investigational	EIF3M	10480	downregulated	entinostat results in decreased expression of EIF3M mRNA	11p13	A21037
Entinostat	Investigational	EIF4EBP1	1978	upregulated	entinostat results in increased expression of EIF4EBP1 mRNA	8p11.23	A21037
Entinostat	Investigational	ELAVL2	1993	downregulated	entinostat results in decreased expression of ELAVL2 mRNA	9p21.3	A21035
Entinostat	Investigational	ELAVL3	1995	upregulated	entinostat results in increased expression of ELAVL3 mRNA	19p13.2	A21037
Entinostat	Investigational	ELF3	1999	upregulated	entinostat results in increased expression of ELF3 mRNA	1q32.1	A21037 A21035
Entinostat	Investigational	ELF4	2000	upregulated	entinostat results in increased expression of ELF4 mRNA	Xq26.1	A21037 A21035
Entinostat	Investigational	ELK3	2004	upregulated	entinostat results in increased expression of ELK3 mRNA	12q23.1	A21037
Entinostat	Investigational	ELL2	22936	upregulated	entinostat results in increased expression of ELL2 mRNA	5q15	A21035
Entinostat	Investigational	ELL3	80237	upregulated	entinostat results in increased expression of ELL3 mRNA	15q15.3	A21037
Entinostat	Investigational	ELMOD1	55531	upregulated	entinostat results in increased expression of ELMOD1 mRNA	11q22.3	A21037

Displaying entries 37026 - 37050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability